Last reviewed · How we verify

Western basis treatment

Liaoning University of Traditional Chinese Medicine · FDA-approved active Small molecule

Western basis treatment is a traditional Chinese medicine formulation designed to address foundational imbalances in the body's physiological systems.

At a glance

Generic nameWestern basis treatment
Also known asAspirin from Liaoning WanLong medicine Co.,Ltd, Atorvastatin calcium (Lipitor) from Liaoning Pharmaceutical foreign trade corporation
SponsorLiaoning University of Traditional Chinese Medicine
ModalitySmall molecule
PhaseFDA-approved

Mechanism of action

As a product from Liaoning University of Traditional Chinese Medicine, this treatment likely operates within the framework of Traditional Chinese Medicine (TCM) theory, targeting underlying constitutional or 'basis' deficiencies. The specific mechanism would involve herbal components selected to restore balance and support the body's natural regulatory functions, though the exact molecular targets are not clearly defined in conventional pharmacological terms.

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: